Cardiovascular benefits of GLP-1 The SELECT trial demonstrated that GLP-1 therapy rapidly reduces heart attacks and strokes. These cardiovascular benefits have long been hinted at in diabetes trials, but the magnitude observed in SELECT surprised even seasoned cardiologists
Tirzepatide is a different molecule (a dual GIP/GLP-1 agonist) that produces greater average weight loss in head-to-head trials
The surge in Ozempic lawsuits filed has prompted coordinated discovery protocols requiring Novo Nordisk and Eli Lilly to produce millions of pages of internal documents, including clinical trial data, adverse event reports, marketing materials, and communications about known risks
The patient who took Rybelsus with sulfonylurea or insulin is advised not to drive or operate machines as it may result in dizziness
Why Patients Choose GoalBMI Wellness Secure telehealth consultations Physician-supervised care GLP-1 medication guidance Insurance and self-pay options Personalized treatment plans Ongoing support and follow-up Care available in English, Spanish, Ukrainian, and Russian Key Takeaways Semaglutide weight loss programs are available in New York through telehealth